End-of-day quote
Mexican S.E.
23:00:00 25/04/2024 BST
|
5-day change
|
1st Jan Change
|
16.3
MXN
|
+3.16%
|
|
+8.23%
|
+15.11%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
11,007
|
18,932
|
19,061
|
21,614
|
16,849
|
15,150
|
15,150
|
-
|
Enterprise Value (EV)
1 |
15,465
|
24,043
|
23,381
|
26,264
|
21,719
|
17,681
|
17,116
|
17,979
|
P/E ratio
|
9.81
x
|
19.3
x
|
12.9
x
|
14.9
x
|
-
|
13.1
x
|
7.41
x
|
7.5
x
|
Yield
|
-
|
-
|
-
|
1.78%
|
-
|
1.38%
|
1.43%
|
2.05%
|
Capitalization / Revenue
|
0.9
x
|
1.48
x
|
1.37
x
|
1.4
x
|
1
x
|
0.8
x
|
0.83
x
|
0.79
x
|
EV / Revenue
|
1.26
x
|
1.88
x
|
1.69
x
|
1.7
x
|
1.29
x
|
1.07
x
|
0.94
x
|
0.94
x
|
EV / EBITDA
|
6.13
x
|
9.35
x
|
7.97
x
|
8.18
x
|
6.26
x
|
5.12
x
|
4.31
x
|
4.24
x
|
EV / FCF
|
59.8
x
|
145
x
|
18
x
|
32.1
x
|
13.4
x
|
8.81
x
|
10.3
x
|
9.68
x
|
FCF Yield
|
1.67%
|
0.69%
|
5.55%
|
3.11%
|
7.49%
|
11.4%
|
9.74%
|
10.3%
|
Price to Book
|
1.64
x
|
2.38
x
|
2.05
x
|
1.96
x
|
-
|
1.44
x
|
1.32
x
|
1.14
x
|
Nbr of stocks (in thousands)
|
943,145
|
1,011,839
|
1,011,744
|
1,006,240
|
994,639
|
929,461
|
929,461
|
-
|
Reference price
2 |
11.67
|
18.71
|
18.84
|
21.48
|
16.94
|
16.30
|
16.30
|
16.30
|
Announcement Date
|
26/02/19
|
26/02/20
|
24/02/21
|
23/02/22
|
22/02/23
|
21/02/24
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
12,282
|
12,756
|
13,867
|
15,460
|
16,859
|
16,467
|
18,203
|
19,185
|
EBITDA
1 |
2,522
|
2,571
|
2,932
|
3,210
|
3,471
|
3,454
|
3,972
|
4,235
|
EBIT
1 |
2,442
|
2,435
|
2,777
|
3,063
|
3,263
|
3,224
|
3,770
|
3,995
|
Operating Margin
|
19.88%
|
19.09%
|
20.03%
|
19.81%
|
19.35%
|
19.58%
|
20.71%
|
20.82%
|
Earnings before Tax (EBT)
1 |
1,915
|
1,536
|
2,247
|
2,313
|
2,261
|
1,685
|
2,946
|
3,429
|
Net income
1 |
1,218
|
986.7
|
1,478
|
1,451
|
1,397
|
1,031
|
2,174
|
2,236
|
Net margin
|
9.91%
|
7.74%
|
10.66%
|
9.39%
|
8.29%
|
6.26%
|
11.95%
|
11.66%
|
EPS
2 |
1.190
|
0.9700
|
1.460
|
1.440
|
-
|
1.080
|
2.200
|
2.173
|
Free Cash Flow
1 |
258.6
|
165.3
|
1,297
|
817.3
|
1,626
|
2,008
|
1,667
|
1,856
|
FCF margin
|
2.11%
|
1.3%
|
9.35%
|
5.29%
|
9.65%
|
12.19%
|
9.16%
|
9.68%
|
FCF Conversion (EBITDA)
|
10.26%
|
6.43%
|
44.23%
|
25.46%
|
46.86%
|
58.13%
|
41.97%
|
43.83%
|
FCF Conversion (Net income)
|
21.24%
|
16.75%
|
87.76%
|
56.33%
|
116.43%
|
194.81%
|
76.66%
|
83.01%
|
Dividend per Share
2 |
-
|
-
|
-
|
0.3817
|
-
|
0.1961
|
0.2331
|
0.3348
|
Announcement Date
|
26/02/19
|
26/02/20
|
24/02/21
|
23/02/22
|
22/02/23
|
21/02/24
|
-
|
-
|
Fiscal Period: December |
2021 Q2
|
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
3,865
|
3,984
|
4,063
|
4,015
|
4,324
|
4,349
|
4,171
|
4,178
|
4,370
|
4,393
|
3,525
|
3,644
|
-
|
-
|
-
|
EBITDA
1 |
776.5
|
819
|
889.9
|
826.6
|
892
|
912.4
|
839.9
|
867.3
|
920.1
|
933.7
|
732.3
|
755
|
-
|
-
|
-
|
EBIT
1 |
742
|
783.4
|
850.7
|
775.2
|
839.8
|
859.4
|
788.4
|
868.8
|
871.1
|
885.8
|
663.5
|
868.8
|
937.4
|
951.7
|
781.5
|
Operating Margin
|
19.2%
|
19.67%
|
20.94%
|
19.31%
|
19.42%
|
19.76%
|
18.9%
|
20.79%
|
19.93%
|
20.16%
|
18.82%
|
23.84%
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
546.7
|
580.8
|
604.5
|
498.8
|
613.6
|
614.2
|
534.8
|
491.3
|
574.9
|
548.3
|
70.58
|
686.9
|
745.8
|
769.7
|
599.5
|
Net income
1 |
379.2
|
393.2
|
359.2
|
339.2
|
404.7
|
399.3
|
253.6
|
358
|
417.4
|
370.7
|
-115.5
|
342.7
|
492.2
|
508
|
395.7
|
Net margin
|
9.81%
|
9.87%
|
8.84%
|
8.45%
|
9.36%
|
9.18%
|
6.08%
|
8.57%
|
9.55%
|
8.44%
|
-3.28%
|
9.4%
|
-
|
-
|
-
|
EPS
2 |
0.3800
|
0.3900
|
0.3600
|
0.3400
|
0.4000
|
0.4000
|
-
|
0.3700
|
0.4300
|
0.3900
|
-0.1200
|
0.3575
|
0.4698
|
0.4874
|
0.4838
|
Dividend per Share
|
-
|
-
|
0.3817
|
-
|
0.3817
|
-
|
-
|
-
|
0.1961
|
0.1961
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
28/07/21
|
27/10/21
|
23/02/22
|
27/04/22
|
27/07/22
|
26/10/22
|
22/02/23
|
26/04/23
|
26/07/23
|
25/10/23
|
21/02/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
4,459
|
5,112
|
4,320
|
4,650
|
4,870
|
4,520
|
1,966
|
2,828
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.768
x
|
1.988
x
|
1.473
x
|
1.449
x
|
1.403
x
|
1.309
x
|
0.495
x
|
0.6678
x
|
Free Cash Flow
1 |
259
|
165
|
1,297
|
817
|
1,626
|
2,008
|
1,667
|
1,857
|
ROE (net income / shareholders' equity)
|
17%
|
12.6%
|
16.8%
|
14.1%
|
13.8%
|
10.6%
|
15.8%
|
15.5%
|
ROA (Net income/ Total Assets)
|
7.16%
|
5.28%
|
7.17%
|
6.51%
|
6.45%
|
4.88%
|
8.21%
|
9.71%
|
Assets
1 |
17,002
|
18,705
|
20,615
|
22,300
|
21,649
|
21,135
|
26,486
|
23,035
|
Book Value Per Share
2 |
7.100
|
7.870
|
9.200
|
11.00
|
-
|
9.830
|
12.40
|
14.30
|
Cash Flow per Share
2 |
1.100
|
0.9900
|
2.000
|
1.440
|
-
|
2.360
|
-
|
-
|
Capex
1 |
868
|
839
|
726
|
630
|
402
|
247
|
546
|
602
|
Capex / Sales
|
7.06%
|
6.58%
|
5.23%
|
4.08%
|
2.38%
|
1.5%
|
3%
|
3.14%
|
Announcement Date
|
26/02/19
|
26/02/20
|
24/02/21
|
23/02/22
|
22/02/23
|
21/02/24
|
-
|
-
|
Last Close Price
16.3
MXN Average target price
20.6
MXN Spread / Average Target +26.38% Consensus |
1st Jan change
|
Capi.
|
---|
| +15.11% | 882M | | +25.83% | 661B | | +27.00% | 566B | | -6.76% | 352B | | +20.34% | 332B | | +3.00% | 283B | | +13.09% | 231B | | +5.46% | 200B | | -9.61% | 195B | | -6.26% | 145B |
Other Pharmaceuticals
|